| Pharmaceutical active ingredients: |
| Methyldopa |
| Available forms, composition and doses of Metholes: |
| N / A |
| Metholes medical category: |
| Human:AntihypertensivesCentral alpha-agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02AB - MethyldopaC02AB02 - Methyldopa (racemic) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Methode d'Adaptation Creme No. 2 | Octinoxate; Oxybenzone; Titanium Dioxide | Esthederm Institut |
| Methofadin | Sulfametomidine | Unidentified Pharmaceutical Company |
| Methofane | Methoxyflurane | Unidentified Pharmaceutical Company |
| Methofazine | Sulfametomidine | Unidentified Pharmaceutical Company |
| Methoin | Mephenytoin | Unidentified Pharmaceutical Company |
| Metholone | Dromostanolone | Unidentified Pharmaceutical Company |
| Methoneuron-C | Folic Acid; Methylcobalamin; Vitamin B3 (Niacinamide); Vitamin C | Almet Corporation |
| Methophylline | Aminophylline | Unidentified Pharmaceutical Company |
| Methopirapone | Metyrapone | Unidentified Pharmaceutical Company |
| Methoplain | Methyldopa | Unidentified Pharmaceutical Company |